Table 1 Details of studies and datasets used for analyses
From: Inflammatory bowel disease and bladder cancer risk: based on a Mendelian randomization study
Exposure or outcome | Study or consortium | Participants(case/control) | Ethnicity | PubMed ID or web source |
|---|---|---|---|---|
Inflammatory bowel disease | IIBDGC | 31,665/33,977 | European | 26,192,919 |
Crohn’s disease | IIBDGC | 17,897/33,977 | European | 26,192,919 |
Ulcerative colitis | IIBDGC | 13,768/33,977 | European | 26,192,919 |
Bladder cancer | United Kingdom Biobank | 2,576/ 417,955 | European | https://pan-ukb-us-east-1.s3.amazonaws.com/sumstats_flat_files/icd10-C67-both_sexes.tsv.bgz |
Bladder cancer | FinnGen | 2,053/287,137 | European | https://storage.googleapis.com/finngen-public-data-r9/summary_stats/finngen_R9_C3_BLADDER_EXALLC.gz |